There exists no clear national or international consensus in key issues of tissue banking. This holds especially true for the fundamental concept of informed consent. During recent years, the harmonization of norms needed for international collaboration has made crucial progress solely in Europe, namely through legal framing. The norms relating to tissue banking are, however, under permanent construction not only in Europe but throughout the world. Consequently, anybody involved in tissue banking is well advised to observe the evolution of the legal and regulatory environment in the particular jurisdiction.

Anderlik M: Commercial biobanks and genetic research: ethical and legal issues. Am J Pharmacogenomics 2003;3:203–215.
Nelkin D, Andrews L: Homo economicus: the commercialization of body tissue in the age of biotechnology. Hastings Cent Rep 1998;28:30–39.
Bauer K, Taub S, Parsi K: Ethical issues in tissue banking for research: a brief review of existing organizational policies. Theor Med Bioeth 2004;25:113–142.
Lin Z, Owen AB, Altman RB: Genomic research and human subject privacy. Science 2004;305:183.
Elger BS, Caplan AL: Consent and anonymization in research involving biobanks. EMBO Rep 2006;7:661–665.
Knoppers BM, Saginur M: The Babel of genetic data terminology. Nat Biotechnol 2005;23:925–927.
Kegley JA: Challenges to informed consent. EMBO Rep 2004;5:832–836.
Maschke KJ, Murray TH: Ethical issues in tissue banking for research: the prospects and pitfalls of setting international standards. Theor Med Bioeth 2004;25:143–155.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.